K
Kenji Uryuhara
Researcher at Kyoto University
Publications - 72
Citations - 2992
Kenji Uryuhara is an academic researcher from Kyoto University. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 27, co-authored 67 publications receiving 2776 citations. Previous affiliations of Kenji Uryuhara include Kyoto Prefectural University of Medicine.
Papers
More filters
Journal ArticleDOI
Impact of graft size mismatching on graft prognosis in liver transplantation from living donors.
Tetsuya Kiuchi,Mureo Kasahara,Kenji Uryuhara,Yukihiro Inomata,Shinji Uemoto,Katsuhiro Asonuma,Hiroto Egawa,Shiro Fujita,Michihiro Hayashi,Koichi Tanaka +9 more
TL;DR: The use of small-for-size grafts (less than 1% of recipient body weight) leads to lower graft survival, probably through enhanced parenchymal cell injury and reduced metabolic and synthetic capacity.
Journal ArticleDOI
Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation.
Hiroto Egawa,Fumitaka Oike,Leo Buhler,A. M. James Shapiro,Sachiko Minamiguchi,Hironori Haga,Kenji Uryuhara,Tetsuya Kiuchi,Satoshi Kaihara,Koichi Tanaka +9 more
TL;DR: ABO-incompatible liver transplantation was carried out with relative safety in infants <1 year old but was not satisfactory in children >1 year in long-term follow-up, and new strategies to prevent antibody-mediated rejection are required.
Journal ArticleDOI
Hepatic grafts from live donors: donor morbidity for 470 cases of live donation.
Shiro Fujita,Ildeok Kim,Kenji Uryuhara,Katsuhiro Asonuma,Hiroto Egawa,Tetsuya Kiuchi,Michihiro Hayashi,Shinji Uemeto,Yukihiro Inomata,Koichi Tanaka +9 more
TL;DR: The morbidity of living donors is low or minimal even for right lobectomy, the most extended procedure, and complete recovery can be expected in all cases.
Journal ArticleDOI
Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University.
Daisuke Morioka,Mureo Kasahara,Yasutsugu Takada,Yasumasa Shirouzu,Kaoru Taira,Seisuke Sakamoto,Kenji Uryuhara,Hiroto Egawa,Hiroshi Shimada,Koichi Tanaka +9 more
TL;DR: LT should be considered to be the definitive treatment for UCDs at this stage, although some issues remain unresolved.
Journal ArticleDOI
Selective Hemi-Portocaval Shunt Based on Portal Vein Pressure for Small-for-Size Graft in Adult Living Donor Liver Transplantation
TL;DR: An algorithm of graft selection in which left lobe donation is considered primarily if the graft‐to‐recipient weight ratio (GRWR) is estimated to be greater than 0.6% in preoperative volumetry with utilization of a hemi‐portocaval shunt based on portal vein pressure (PVP) more than 20 mmHg is developed.